Sun Pharma Advanced Research’s net loss narrows to Rs 56.72 crore in Q4

18 May 2021 Evaluate

Sun Pharma Advanced Research Company has reported results for fourth quarter and year ended March 31, 2021.

The company has reported net loss at Rs 56.72 crore for the quarter under review as compared to net loss of Rs 99.54 crore for the same quarter in the previous year. Total income of the company increased by 9.91% at Rs 28.39 crore for Q4FY21 as compared Rs 25.83 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported net loss at Rs 151.14 crore as compared to net loss of Rs 312.40 crore for the previous year. Total income of the company reported above 2- fold jump at Rs 258.37 crore for year under review as compared to Rs 86.58 crore for year ended March 31, 2020.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×